Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects



Rating:

Share or cite this content

Citations should be made in the following way:
Z. S. Uyan, G. Unluguzel, G. Haklar, E. Cakir, S. Oktem, R. Ersu, B. Karadag, F. Karakoc, E. Dagli (Istanbul, Turkey). The effect of inhaled steroids on bronchial hyperreactivity, oxidative status, clinical and inflammatory paramerters in patients with cystic fibrosis. Eur Respir J 2007; 30: Suppl. 51, 3771

Member's Comments

No comment yet.

Related content which might interest you: Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003 Assessment of bronchial hyperreactivity, maximal airway response and response to inhaled corticosteriod treatment in patients with bronchiectasis Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 The influence of obesity on bronchial hyperresponsiveness, airway and systemic inflammation, lung function and quality of life in patients with asthma Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008 Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 The clinical importance of measuring airway inflammation Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management Year: 2005 Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Mechanisms and markers of airway inflammation in cystic fibrosis Source: Eur Respir J 2002; 19: 333-340 Year: 2002 Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006 Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Source: Eur Respir J 2001; 18: 444-450 Year: 2001 The effects of capsaicin on airway inflammation in asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 586s Year: 2004 Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD Source: Eur Respir J 2012; 40: 1098-1105 Year: 2012 Airway inflammation in COPD: physiological outcome measures and induced sputum Source: Eur Respir J 2003; 21: 19S-28S Year: 2003 Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma Source: Eur Respir J 2006; 27: 172-187 Year: 2006 Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis Source: Eur Respir J 2002; 20: 122-126 Year: 2002 Effects of formoterol-budesonide combination on residual eosinophilic inflammation in distal airway of patients with well-controlled moderate asthma Source: Annual Congress 2011 - Asthma management and response Year: 2011 Anti-inflammatory effect of budesonide on the central and peripheral airway inflammation in cough-variant and mild bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Systemic and airway inflammation and the presence of emphysema in patients with COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Effects of salmeterol/fluticasone propionate (SFC) on airway inflammation in induced sputum in COPD Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005 Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014 Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002